| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 438,892 | 399,613 | 362,422 | 355,109 | | Cost of Revenue | 558,618 | 191,674 | 185,016 | 199,550 | | | Gross Profit | (119,726) | 207,939 | 177,406 | 155,559 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 54,746 | 52,118 | 46,887 | 53,453 | | Non Recurring | 383 |
-
| 261 | 16,678 | | Others | (242,238) | 122,254 | 119,984 | 132,739 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 67,383 | 33,567 | 10,274 | (47,311) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,569 | 9,409 | 5,045 | (20,832) | | Earnings Before Interest And Taxes | 72,952 | 42,976 | 15,319 | (68,143) | | Interest Expense | 24,554 | 22,922 | 26,154 | 40,772 | | Income Before Tax | 48,398 | 20,054 | (10,835) | (108,915) | | Income Tax Expense | 18,304 | 7,650 | (1,895) | (36,737) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,094 | 12,404 | (8,940) | (72,178) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,094 | 12,404 | (8,940) | (72,178) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,094 | $12,404 | ($8,940) | ($72,178) |
|
0.52% Nasdaq 
Income Statement
